Drug Store News - Ortho-McNeil
Saturday, December 27th, 2008 The FDA last month approved a new five-day 750 mg once-daffy regimen of Ortho-McNeil’s Levaquin (levofloxacin) to treat acute bacterial sinusitis.
The newly approved regimen is as effective as a 10-day course of Levaquin 500 mg. Levaquin generated $1.3 billion in sales in 2004.
Related Results
Levaquin a…
